Philip M Hansbro Selected Research

dimethyl sulfoxide reductase (DMSO reductase)

1/2021

The DmsABC Sulfoxide Reductase Supports Virulence in Non-typeable Haemophilus influenzae.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Philip M Hansbro Research Topics

Disease

73	Inflammation (Inflammations) 10/2022 - 01/2008
66	Asthma (Bronchial Asthma) 10/2022 - 03/2004
66	Chronic Obstructive Pulmonary Disease (COPD) 10/2022 - 01/2010
48	Infections 03/2022 - 02/2004
28	Respiratory Tract Diseases (Respiratory Tract Disease) 03/2022 - 05/2013
20	Lung Diseases (Lung Disease) 04/2022 - 12/2014
18	Respiratory Hypersensitivity 10/2022 - 01/2010
14	Neoplasms (Cancer) 07/2022 - 01/2017
13	Lung Neoplasms (Lung Cancer) 07/2022 - 01/2017
13	Fibrosis (Cirrhosis) 01/2021 - 06/2014
12	Airway Remodeling 07/2022 - 03/2013
11	Pneumonia (Pneumonitis) 01/2022 - 03/2011
10	Human Influenza (Influenza) 10/2021 - 06/2011
9	Respiratory Tract Infections (Respiratory Tract Infection) 02/2022 - 01/2017
8	Disease Progression 06/2022 - 01/2008
7	Emphysema 07/2022 - 03/2013
7	Necrosis 01/2022 - 05/2011
6	Tuberculosis (Tuberculoses) 06/2022 - 01/2018
6	COVID-19 02/2022 - 07/2020
6	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2020 - 01/2017
5	Obesity 01/2022 - 01/2018
5	Virus Diseases (Viral Diseases) 10/2021 - 01/2012
5	Cystic Fibrosis (Mucoviscidosis) 01/2020 - 01/2010
4	Idiopathic Pulmonary Fibrosis 01/2020 - 06/2016
4	Colitis 01/2019 - 06/2014
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2022 - 07/2021
3	Bacterial Infections (Bacterial Infection) 01/2016 - 07/2012
3	Wounds and Injuries (Trauma) 11/2015 - 10/2014
2	Infection with Mycobacterium marinum 01/2022 - 12/2020
2	Carcinoma (Carcinomatosis) 07/2021 - 01/2021
2	Melanoma (Melanoma, Malignant) 01/2021 - 01/2018
2	Pathologic Processes 01/2021 - 01/2017

Drug/Important Bio-Agent (IBA)

41	CytokinesIBA 01/2022 - 09/2007
33	SmokeIBA 10/2022 - 03/2013
30	Proteins (Proteins, Gene)FDA Link 07/2022 - 06/2011
21	SteroidsIBA 01/2022 - 08/2010
17	Pharmaceutical PreparationsIBA 01/2022 - 01/2017
15	Messenger RNA (mRNA)IBA 07/2022 - 06/2014
15	Interleukin-13IBA 01/2022 - 01/2010
14	MicroRNAs (MicroRNA)IBA 11/2021 - 05/2013
12	InflammasomesIBA 01/2022 - 12/2015
11	CollagenIBA 10/2022 - 01/2010
11	Antiviral Agents (Antivirals)IBA 02/2022 - 06/2011
10	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2013
8	AntioxidantsIBA 06/2022 - 01/2011
8	Interleukin-5 (Interleukin 5)IBA 01/2022 - 09/2007
8	LigandsIBA 11/2021 - 12/2014
8	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 12/2014
7	AllergensIBA 02/2021 - 01/2008
7	OvalbuminIBA 01/2021 - 09/2007
6	AntigensIBA 10/2022 - 09/2007
6	ChemokinesIBA 11/2021 - 08/2015
6	InterferonsIBA 09/2021 - 05/2011
6	Interleukin-17 (Interleukin 17)IBA 01/2021 - 05/2011
5	Immunoglobulin E (IgE)IBA 01/2022 - 01/2008
5	Bleomycin (Blenoxane)FDA LinkGeneric 01/2021 - 01/2018
5	Biological ProductsIBA 01/2020 - 10/2010
5	Fibronectins (Fibronectin)IBA 11/2018 - 10/2010
4	BerberineIBA 07/2022 - 11/2021
4	Reactive Oxygen Species (Oxygen Radicals)IBA 04/2022 - 04/2015
4	Liposomes (Liposome)IBA 03/2022 - 11/2018
4	NucleotidesIBA 01/2022 - 01/2017
4	Toll-Like Receptors (Toll-Like Receptor)IBA 01/2022 - 01/2017
4	IronIBA 12/2021 - 01/2017
4	VaccinesIBA 11/2021 - 12/2010
4	Methacholine Chloride (Methacholine)FDA Link 01/2021 - 06/2014
4	Peptides (Polypeptides)IBA 03/2020 - 01/2014
4	Dexamethasone (Maxidex)FDA LinkGeneric 01/2020 - 05/2015
4	Anti-Bacterial Agents (Antibiotics)IBA 01/2020 - 05/2015
4	Fingolimod Hydrochloride (FTY720)FDA Link 02/2019 - 01/2016
4	Fatty Acids (Saturated Fatty Acids)IBA 01/2019 - 01/2018
4	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019 - 12/2014
4	Interleukin-6 (Interleukin 6)IBA 11/2018 - 06/2014
3	Bronchodilator Agents (Bronchodilators)IBA 09/2022 - 12/2014
3	AlkaloidsIBA 07/2022 - 04/2022
3	Peptide Hydrolases (Proteases)FDA Link 07/2022 - 01/2021
3	Oxidants (Oxidizing Agents)IBA 06/2022 - 01/2020
3	Dendrimers (Dendrons)IBA 03/2022 - 11/2018
3	Phosphotransferases (Kinase)IBA 01/2022 - 12/2020
3	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 01/2022 - 01/2017
3	Interleukin-33IBA 11/2021 - 12/2017
3	Rutin (Rutoside)IBA 07/2021 - 10/2020
3	UbiquitinIBA 01/2021 - 12/2017
3	AntagomirsIBA 01/2021 - 01/2015
3	platelet activating factor receptorIBA 01/2020 - 01/2017
3	LipopolysaccharidesIBA 01/2020 - 02/2015
3	Glycoproteins (Glycoprotein)IBA 05/2019 - 01/2012
3	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 02/2019 - 12/2016
3	Extracellular Matrix ProteinsIBA 01/2019 - 10/2010
3	InterleukinsIBA 12/2017 - 05/2011
3	GlucocorticoidsIBA 03/2013 - 08/2010
2	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 09/2022 - 07/2016
2	isoquinolineIBA 07/2022 - 05/2022
2	LipidsIBA 03/2022 - 11/2020
2	Small Interfering RNA (siRNA)IBA 02/2022 - 01/2019
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2017
2	CC ChemokinesIBA 01/2022 - 11/2021

Therapy/Procedure

52	Therapeutics 06/2022 - 01/2008
3	Immunomodulation 09/2021 - 11/2007
3	Microspheres (Microsphere) 01/2020 - 11/2018